ACE and hypertensive disorder: In addition, patients in the basal insulin group had lower prevalence rates of hypertension and dyslipidemia and used less related drugs, including angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), and statins, than those in the other groups.